Page last updated: 2024-08-23

mifepristone and metribolone

mifepristone has been researched along with metribolone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Du, X; Eksterowicz, J; Fantin, VR; Huang, E; Huang, T; Jackson, E; Jahchan, N; Kawai, H; McGee, LR; Medina, JC; Rew, Y; Sun, D; Sutimantanapi, D; Waszczuk, J; Yan, X; Ye, Q; Zavorotinskaya, T; Zhou, H; Zhu, L1
Berrevoets, CA; Brinkmann, AO; Umar, A1
Agoulnik, IU; Amrikachi, M; Ayala, GE; Bingman, WE; Krause, WC; Rahman, HT; Weigel, NL1
Berrevoets, CA; Brinkmann, AO; Trapman, J; Umar, A1
Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T1
Cai, Y; Conzen, SD; Isikbay, M; Kach, J; Kregel, S; Otto, K; Szmulewitz, RZ; Vander Griend, DJ1

Reviews

1 review(s) available for mifepristone and metribolone

ArticleYear
Antiandrogens: selective androgen receptor modulators.
    Molecular and cellular endocrinology, 2002, Dec-30, Volume: 198, Issue:1-2

    Topics: Androgen Antagonists; Androgens; Animals; Cell Line; Gene Expression Regulation; Humans; Male; Metribolone; Mifepristone; Protein Binding; Receptors, Androgen

2002

Other Studies

5 other study(ies) available for mifepristone and metribolone

ArticleYear
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
    Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

    Topics: Animals; Drug Discovery; Female; Hormone Antagonists; Humans; Mice; Ovarian Neoplasms; Rats; Receptors, Glucocorticoid; Swine; Swine, Miniature; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Repressors of androgen and progesterone receptor action.
    The Journal of biological chemistry, 2003, Aug-15, Volume: 278, Issue:33

    Topics: Animals; Binding Sites; Breast Neoplasms; COS Cells; DAX-1 Orphan Nuclear Receptor; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Hormone Antagonists; Humans; Hydroxamic Acids; Male; Metribolone; Mifepristone; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Co-Repressor 2; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Receptors, Androgen; Receptors, Calcitriol; Receptors, Interferon; Receptors, Progesterone; Receptors, Retinoic Acid; Repressor Proteins; Testosterone Congeners; Tumor Suppressor Protein p53

2003
Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
    The Biochemical journal, 2004, May-01, Volume: 379, Issue:Pt 3

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Animals; Binding, Competitive; Cell Line, Tumor; CHO Cells; Cricetinae; Cyproterone Acetate; Down-Regulation; Gene Expression Regulation; Ligands; Male; Metribolone; Mice; Mifepristone; Mutation; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Coactivator 2; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Repressor Proteins; Transcription Factors; Transcription, Genetic; Transfection

2004
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
    Molecular and cellular biology, 2007, Volume: 27, Issue:5

    Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic

2007
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
    Hormones & cancer, 2014, Volume: 5, Issue:2

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzoates; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Dexamethasone; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Immediate-Early Proteins; Immunoblotting; Male; Metribolone; Mice; Mice, Nude; Microscopy, Fluorescence; Mifepristone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Receptors, Androgen; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays

2014